Complicated Skin and Soft Tissue Infections
📧 Sign up to get email alerts when something new happens for Complicated Skin and Soft Tissue Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-06FDA Approved: TIGECYCLINE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for tigecycline from Apotex Corp, indicating an approved addition or update under the supplemental f…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review Study
A retrospective chart review comparing nemonoxacin with other anti-MRSA therapies for complicated skin and soft tissue infections, with the …
-
FDA approval · 2024-11-21FDA Approved: DAPTOMYCIN — Original Application (Par Health USA, LLC)
FDA approves the original application for daptomycin by Par Health USA, LLC, authorizing its use as an antibiotic for certain serious infect…
-
FDA approval · 2018-08-02FDA Approved: TIGECYCLINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for tigecycline, authorizing a generic injectable antibiotic. It covers indic…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections [Phase 3]
Phase 3 trial update comparing tigecycline to vancomycin with aztreonam for complicated skin and soft tissue infections; the study has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections
AstraZeneca-sponsored trial evaluating management of patients with community-acquired pneumonia and complicated skin and soft tissue infecti…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections [Phase 2]
Phase 2 trial comparing ceftaroline fosamil to linezolid in adults with complicated skin and soft tissue infections; results on efficacy and…
-
CLINICAL_TRIALS withdrawal · 2012-05-09Clinical Trial Update: Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) [Phase 3]
Phase 3 study of PTK 0796 (omadacycline) for complicated skin and soft tissue infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections [Phase 3]
A Phase 3 study evaluating daptomycin in elderly patients with complicated skin and soft tissue infections has completed, and results have b…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections [Phase 3]
A Phase 3 trial evaluating the safety and effectiveness of levofloxacin compared with ticarcillin/clavulanate (used alone or after amoxicill…
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections [Phase 3]
A Phase 3 trial compared ceftaroline fosamil (Teflaro) with vancomycin plus aztreonam in adults with complicated skin and soft tissue infect…